He reveals that institutional investors took part in the placing for £27.3mln, which is subject to shareholder approval. The amount raised could rise to £40mln or so if the demand is there, with an option granted to the joint bookrunners to find subscribers for an additional 5.3mln shares.
Silence Therapeutics CEO on £40mln fundraise
Quick facts: Silence Therapeutics PLC
Price: 446 GBX
Market Cap: £369.27 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Silence Therapeutics PLC named herein, including the promotion by the Company of Silence Therapeutics PLC in any Content on the Site, the...FOR OUR FULL DISCLAIMER CLICK HERE